National Health Investors Inc financial data

Symbol
NHI on NYSE
Location
222 Robert Rose Drive, Murfreesboro, TN
State of incorporation
MD
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 25, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 95.6 % -1.13%
Return On Equity 10.8 % +1.13%
Return On Assets 5.5 % +1.66%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 45.7M shares +5.21%
Common Stock, Shares, Outstanding 45.7M shares +5.25%
Entity Public Float 2.81B USD +29.6%
Common Stock, Value, Issued 457K USD +5.3%
Weighted Average Number of Shares Outstanding, Basic 43.8M shares +1.05%
Weighted Average Number of Shares Outstanding, Diluted 44.1M shares +1.64%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 335M USD +4.8%
Revenue from Contract with Customer, Excluding Assessed Tax 54.4M USD +11.5%
General and Administrative Expense 20.7M USD +7.36%
Net Income (Loss) Attributable to Parent 138M USD +1.72%
Earnings Per Share, Basic 3.14 USD/shares +0.32%
Earnings Per Share, Diluted 3.13 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 24.3M USD +8.69%
Property, Plant and Equipment, Net 2.21B USD +4.94%
Operating Lease, Right-of-Use Asset 1.52M USD -2.43%
Assets 2.61B USD +5.06%
Liabilities 1.23B USD +1.22%
Retained Earnings (Accumulated Deficit) 2.6B USD +5.59%
Stockholders' Equity Attributable to Parent 1.37B USD +8.97%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1.38B USD +8.78%
Liabilities and Equity 2.61B USD +5.06%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 40.8M USD +31.5%
Net Cash Provided by (Used in) Financing Activities -35.9M USD -277%
Net Cash Provided by (Used in) Investing Activities -16.2M USD +41.2%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 45.7M shares +5.25%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.3M USD -88.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 26.5M USD +7.66%
Interest Paid, Excluding Capitalized Interest, Operating Activities 16.9M USD +6.75%
Deferred Tax Assets, Gross 900K USD -59.1%
Operating Lease, Liability 1.69M USD -1.17%
Depreciation 71.4M USD +2.1%
Property, Plant and Equipment, Gross 2.95B USD +6.23%
Lessee, Operating Lease, Liability, to be Paid, Year Two 100K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 100K USD 0%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.2M USD -7.69%
Lessee, Operating Lease, Liability, to be Paid, Year Three 100K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 100K USD 0%
Share-based Payment Arrangement, Expense 4.18M USD -9.19%
Interest Expense 59.9M USD +3%